๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Polyfunctional Cytomegalovirus-Specific Immunity in Lung Transplant Recipients Receiving Valganciclovir Prophylaxis

โœ Scribed by L. D. Snyder; R. Medinas; C. Chan; S. Sparks; W. A Davis; S. M. Palmer; K. J. Weinhold

Book ID
114805859
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
605 KB
Volume
11
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Valganciclovir for cytomegalovirus proph
Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients
โœ Jeong M. Park; Kathleen D. Lake; Robert J. Fontana ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 48 KB

We thank Jain et al. for their interest and correspondence regarding our recently published study. 1 The authors note that the incidence of cytomegalovirus (CMV) disease in our retrospective study was much lower than that reported by others. As acknowledged in our article, we did not use routine sur

Increased incidence of cytomegalovirus i
Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis
โœ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos